title: [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin].
authors.forename: M
authors.initials: M
authors.lastname: Barreales
authors.forename: G
authors.initials: G
authors.lastname: Castellano
authors.forename: I
authors.initials: I
authors.lastname: Fernández
authors.forename: R
authors.initials: R
authors.lastname: Muñoz
authors.forename: M
authors.initials: M
authors.lastname: Manzano
authors.forename: J A
authors.initials: JA
authors.lastname: Solís Herruzo
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a